Company news
Surenano Science Ltd (CSE:SURE) news
Surenano Science Ltd news releases on 6ix. Latest, Apr 24, 2026: SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44…
Press releases & updates
SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio
April 24, 2026
SureNano Science Ltd. Acquires GlucaPharm Inc., Advancing Second-Generation FDA Pathway GLP-1 Drug Development
February 23, 2026
SureNano Announces Stock Option Grant
December 12, 2025
SureNano Announces Closing of $1,250,000 Private Placement
December 10, 2025
SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development
November 19, 2025
SureNano Announces Private Placement
November 5, 2025
SureNano Closes Financing
September 19, 2025
SureNano Announces Funding, Debt Settlement and AGSM Results
August 22, 2025
SureNano Science Announces DTC Eligibility
January 17, 2023